It is one of several genes located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer.

2024年12月25日 · Complete information for RRM1 gene (Protein Coding), Ribonucleotide Reductase Catalytic Subunit M1, including: function, proteins, disorders, pathways, orthologs, and expression.

2024年12月18日 · Ribonucleotide reductase M1 (RRM1), the catalytic subunit of ribonucleotide reductase, plays a pivotal role in converting ribonucleotides (NTP) into deoxyribonucleotides (dNTP), essential for...

We demonstrate that RRM1 knockdown and an RRM1 inhibitor clofarabine (CLO), alone and especially when combined with melphalan, triggers significant MM cell growth inhibition both in vitro and in vivo in a mouse human MM xenograft model.

RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeling in pancreatic cancer. Targeting Ribonucleotide Reductase Induces Synthetic Lethality in PP2A-Deficient Uterine Serous Carcinoma.

2022年8月1日 · Ferroptosis, a type of regulated cell death brought about by lipid peroxidation, has been discovered to suppress tumor growth. Here, we report that targeting RRM1 promotes ferroptosis and affects...

2020年7月25日 · Ribonucleotide reductase (RNR) catalyzes the rate-limiting step of de novo synthesis of deoxyribonucleotide triphosphates (dNTPs) building blocks for DNA synthesis, and is a well-recognized target...

2017年9月1日 · We then characterized the effect of genetic and pharmacologic inhibition of ribonucleotide reductase catalytic subunit M1 (RRM1) on multiple myeloma growth and survival using siRNA and clofarabine, respectively, in both in vitro and in vivo mouse xenograft models.

2024年12月10日 · Clinical resource with information about RRM1, Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 6, and available tests.

Ribonucleotide reductase large subunit M1 (RRM1), an enzyme in the DNA synthesis pathway, is upregulated during gemcitabine resistance, and its expression is associated with worse prognosis for pancreatic cancer.